The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Epidemiology and treatment of pulmonary arterial hypertension
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationAuthors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Self-citationD'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Barst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Primary Pulmonary Hypertension: A National Prospective Study
RICH, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., DETRE, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,039
Pulmonary Arterial Hypertension in France: Results from a National Registry
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 2,000
Self-citationExpression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Definitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,735
Treatment of Pulmonary Arterial Hypertension
Humbert, M., Sitbon, O., & Simonneau, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040291 · Cited by 1,707
Self-citationCellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Self-citationBenza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Pulido, T., Adzerikho, I., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H.-A., Jansa, P., Jing, Z.-C., Le Brun, F.-O., Mehta, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213917 · Cited by 1,443
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Ghofrani, H.-A., D'Armini, A. M., Grimminger, F., Hoeper, M. M., Jansa, P., Kim, N. H., Mayer, E., Simonneau, G., Wilkins, M. R., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209657 · Cited by 1,401
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911818 · Cited by 1,399
Self-citationGiaid, A., & Saleh, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,369
Riociguat for the treatment of pulmonary arterial hypertension
Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209655 · Cited by 1,346
Self-citationInitial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Galiè, N., Barberà, J. A., Frost, A. E., Ghofrani, H.-A., Hoeper, M. M., McLaughlin, V. V., Peacock, A. J., Simonneau, G., Vachiery, J.-L., Grünig, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413687 · Cited by 1,182
Pulmonary Arterial Hypertension
Badesch, D. B., Raskob, G. E., Elliott, C. G., Krichman, A. M., Farber, H. W., Frost, A. E., Barst, R. J., Benza, R. L., Liou, T. G., Turner, M., et al. (2010) · Chest · doi:10.1378/chest.09-1140 · Cited by 1,178
Benza, R. L., Miller, D. P., Barst, R. J., Badesch, D. B., Frost, A. E., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-1460 · Cited by 1,104
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,103
Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
Forfia, P. R., Fisher, M. R., Mathai, S. C., Housten-Harris, T., Hemnes, A. R., Borlaug, B. A., Chamera, E., Corretti, M. C., Champion, H. C., Abraham, T. P., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-547oc · Cited by 1,090
Galiè, N., Olschewski, H., Oudiz, R. J., Torres, F., Frost, A., Ghofrani, H. A., Badesch, D. B., McGoon, M. D., McLaughlin, V. V., Roecker, E. B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.742510 · Cited by 1,083
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
Right Heart Adaptation to Pulmonary Arterial Hypertension
Vonk-Noordegraaf, A., Haddad, F., Chin, K. M., Forfia, P. R., Kawut, S. M., Lumens, J., Naeije, R., Newman, J., Oudiz, R. J., Provencher, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.027 · Cited by 982
van de Veerdonk, M. C., Kind, T., Marcus, J. T., Mauritz, G.-J., Heymans, M. W., Bogaard, H.-J., Boonstra, A., Marques, K. M. J., Westerhof, N., & Vonk-Noordegraaf, A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.068 · Cited by 846
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Self-citationAn epidemiological study of pulmonary arterial hypertension
Peacock, A. J., Murphy, N. F., McMurray, J. J. V., Caballero, L., & Stewart, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092306 · Cited by 792
van Wolferen, S. A., Marcus, J. T., Boonstra, A., Marques, K. M. J., Bronzwaer, J. G. F., Spreeuwenberg, M. D., Postmus, P. E., & Vonk-Noordegraaf, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl477 · Cited by 753
Left ventricular heart failure and pulmonary hypertension
Rosenkranz, S., Gibbs, J. S. R., Wachter, R., De Marco, T., Vonk-Noordegraaf, A., & Vachiéry, J.-L. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv512 · Cited by 692
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Humbert, M., Sitbon, O., Yaïci, A., Montani, D., O'Callaghan, D. S., Jaïs, X., Parent, F., Savale, L., Natali, D., Günther, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00057010 · Cited by 674
Self-citationCombination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
Humbert, M., Barst, R. J., Robbins, I. M., Channick, R. N., Galiè, N., Boonstra, A., Rubin, L. J., Horn, E. M., Manes, A., & Simonneau, G. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00028404 · Cited by 640
Self-citationRandomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
McLaughlin, V. V., Oudiz, R. J., Frost, A., Tapson, V. F., Murali, S., Channick, R. N., Badesch, D. B., Barst, R. J., Hsu, H. H., & Rubin, L. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-358oc · Cited by 626
Genetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R., Grünig, E., Aldred, M., Geraci, M., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 616
Self-citationSimonneau, G., Rubin, L. J., Galiè, N., Barst, R. J., Fleming, T. R., Frost, A. E., Engel, P. J., Kramer, M. R., Burgess, G., Collings, L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-8-200810210-00004 · Cited by 616
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Stasch, J.-P., Pacher, P., & Evgenov, O. V. (2011) · Circulation · doi:10.1161/circulationaha.110.981738 · Cited by 601
Hirata, Y., Emori, T., Eguchi, S., Kanno, K., Imai, T., Ohta, K., & Marumo, F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116338 · Cited by 568
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
McLaughlin, V. V., Benza, R. L., Rubin, L. J., Channick, R. N., Voswinckel, R., Tapson, V. F., Robbins, I. M., Olschewski, H., Rubenfire, M., & Seeger, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.027 · Cited by 566
Ling, Y., Johnson, M. K., Kiely, D. G., Condliffe, R., Elliot, C. A., Gibbs, J. S. R., Howard, L. S., Pepke-Zaba, J., Sheares, K. K. K., Corris, P. A., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0383oc · Cited by 560
Benza, R. L., Gomberg-Maitland, M., Miller, D. P., Frost, A., Frantz, R. P., Foreman, A. J., Badesch, D. B., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-0676 · Cited by 557
NO-independent regulatory site on soluble guanylate cyclase
Stasch, J.-P., Becker, E. M., Alonso-Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Gerzer, R., Minuth, T., Perzborn, E., Pleiß, U., et al. (2001) · Nature · doi:10.1038/35065611 · Cited by 545
BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension
Machado, R. D., Pauciulo, M. W., Thomson, J. R., Lane, K. B., Morgan, N. V., Wheeler, L., Phillips III, J. A., Newman, J., Williams, D., Galiè, N., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316947 · Cited by 535
Self-citationPulmonary Arterial Hypertension
McGoon, M. D., Benza, R. L., Escribano-Subias, P., Jiang, X., Miller, D. P., Peacock, A. J., Pepke-Zaba, J., Pulido, T., Rich, S., Rosenkranz, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.023 · Cited by 524
Self-citationCyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function
Rybalkin, S. D., Yan, C., Bornfeldt, K. E., & Beavo, J. A. (2003) · Circulation Research · doi:10.1161/01.res.0000087541.15600.2b · Cited by 511
Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
Barst, R. J., Gibbs, J. S. R., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V. V., Rubin, L. J., Sitbon, O., Tapson, V. F., & Galiè, N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.017 · Cited by 499
Ambrisentan Therapy for Pulmonary Arterial Hypertension
Galié, N., Badesch, D., Oudiz, R., Simonneau, G., McGoon, M. D., Keogh, A. M., Frost, A. E., Zwicke, D., Naeije, R., Shapiro, S., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.050 · Cited by 494
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
Thenappan, T., Shah, S. J., Rich, S., Tian, L., Archer, S. L., & Gomberg-Maitland, M. (2010) · European Respiratory Journal · doi:10.1183/09031936.00072709 · Cited by 493
A Novel Channelopathy in Pulmonary Arterial Hypertension
Ma, L., Roman-Campos, D., Austin, E. D., Eyries, M., Sampson, K. S., Soubrier, F., Germain, M., Trégouët, D.-A., Borczuk, A., Rosenzweig, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211097 · Cited by 477
Self-citationPlatelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Montani, D., Dorfmüller, P., Durand-Gasselin, I., Tcherakian, C., Le Pavec, J., Mazmanian, M., Fadel, E., Mussot, S., Mercier, O., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1037oc · Cited by 472
Self-citationHoeper, M. M., Huscher, D., Ghofrani, H. A., Delcroix, M., Distler, O., Schweiger, C., Grunig, E., Staehler, G., Rosenkranz, S., Halank, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.026 · Cited by 466
McMurtry, M. S., Bonnet, S., Wu, X., Dyck, J. R. B., Haromy, A., Hashimoto, K., & Michelakis, E. D. (2004) · Circulation Research · doi:10.1161/01.res.0000145360.16770.9f · Cited by 453
Morrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Evans, J. D. W., Girerd, B., Montani, D., Wang, X.-J., Galiè, N., Austin, E. D., Elliott, G., Asano, K., Grünig, E., Yan, Y., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00544-5 · Cited by 446
Self-citationA USA-based registry for pulmonary arterial hypertension: 1982–2006
Thenappan, T., Shah, S. J., Rich, S., & Gomberg-Maitland, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00042107 · Cited by 432
Yuan, J. X.-J., Aldinger, A. M., Juhaszova, M., Wang, J., Conte, J. V., Gaine, S. P., Orens, J. B., & Rubin, L. J. (1998) · Circulation · doi:10.1161/01.cir.98.14.1400 · Cited by 425
Survival in pulmonary hypertension in Spain: insights from the Spanish registry
Escribano-Subias, P., Blanco, I., López-Meseguer, M., Lopez-Guarch, C. J., Roman, A., Morales, P., Castillo-Palma, M. J., Segovia, J., Gómez-Sanchez, M. A., & Barberà, J. A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00101211 · Cited by 415
Inflammation in Pulmonary Arterial Hypertension
Price, L. C., Wort, S. J., Perros, F., Dorfmüller, P., Huertas, A., Montani, D., Cohen-Kaminsky, S., & Humbert, M. (2012) · Chest · doi:10.1378/chest.11-0793 · Cited by 403
Self-citationKawut, S. M., Lima, J. A. C., Barr, R. G., Chahal, H., Jain, A., Tandri, H., Praestgaard, A., Bagiella, E., Kizer, J. R., Johnson, W. C., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.985515 · Cited by 390
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E. A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00116313 · Cited by 382
Self-citationTapson, V. F., Torres, F., Kermeen, F., Keogh, A. M., Allen, R. P., Frantz, R. P., Badesch, D. B., Frost, A. E., Shapiro, S. M., Laliberte, K., et al. (2012) · Chest · doi:10.1378/chest.11-2212 · Cited by 378
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Humbert, M., Lau, E. M. T., Montani, D., Jaïs, X., Sitbon, O., & Simonneau, G. (2014) · Circulation · doi:10.1161/circulationaha.114.006974 · Cited by 342
Self-citationPharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
Iglarz, M., Binkert, C., Morrison, K., Fischli, W., Gatfield, J., Treiber, A., Weller, T., Bolli, M. H., Boss, C., Buchmann, S., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142976 · Cited by 329
Jing, Z.-C., Parikh, K., Pulido, T., Jerjes-Sanchez, C., White, R. J., Allen, R., Torbicki, A., Xu, K.-F., Yehle, D., Laliberte, K., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.124388 · Cited by 326
ET A and ET B Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells
DAVIE, N., HALEEN, S. J., UPTON, P. D., POLAK, J. M., YACOUB, M. H., MORRELL, N. W., & WHARTON, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.3.2104059 · Cited by 314
The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups
Gall, H., Felix, J. F., Schneck, F. K., Milger, K., Sommer, N., Voswinckel, R., Franco, O. H., Hofman, A., Schermuly, R. T., Weissmann, N., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.02.016 · Cited by 313
Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Dorfmüller, P., Montani, D., Hammad, H., Waelput, W., Girerd, B., Raymond, N., Mercier, O., Mussot, S., Cohen-Kaminsky, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0927oc · Cited by 308
Self-citationPre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension
Opitz, C. F., Hoeper, M. M., Gibbs, J. S. R., Kaemmerer, H., Pepke-Zaba, J., Coghlan, J. G., Scelsi, L., D’Alto, M., Olsson, K. M., Ulrich, S., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.047 · Cited by 307
Tapson, V. F., Jing, Z.-C., Xu, K.-F., Pan, L., Feldman, J., Kiely, D. G., Kotlyar, E., McSwain, C. S., Laliberte, K., Arneson, C., et al. (2013) · Chest · doi:10.1378/chest.12-2875 · Cited by 297
Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort
Strange, G., Playford, D., Stewart, S., Deague, J. A., Nelson, H., Kent, A., & Gabbay, E. (2012) · Heart · doi:10.1136/heartjnl-2012-301992 · Cited by 296
Results of European post-marketing surveillance of bosentan in pulmonary hypertension
Humbert, M., Segal, E. S., Kiely, D. G., Carlsen, J., Schwierin, B., & Hoeper, M. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00138706 · Cited by 295
Self-citationCombining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Hoeper, M. M., Leuchte, H., Halank, M., Wilkens, H., Meyer, F. J., Seyfarth, H. J., Wensel, R., Ripken, F., Bremer, H., Kluge, S., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00057906 · Cited by 288
Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Fleming, T. R., Galiè, N., Simonneau, G., Ghofrani, H. A., Oakes, M., Layton, G., Serdarevic-Pehar, M., McLaughlin, V. V., et al. (2011) · Chest · doi:10.1378/chest.10-0969 · Cited by 259
Causes and Circumstances of Death in Pulmonary Arterial Hypertension
Tonelli, A. R., Arelli, V., Minai, O. A., Newman, J., Bair, N., Heresi, G. A., & Dweik, R. A. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1640oc · Cited by 258
Halpern, S. D., & Taichman, D. B. (2009) · Chest · doi:10.1378/chest.08-2784 · Cited by 245
Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
Lajoie, A. C., Lauzière, G., Lega, J.-C., Lacasse, Y., Martin, S., Simard, S., Bonnet, S., & Provencher, S. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00027-8 · Cited by 235
Jacobs, W., van de Veerdonk, M. C., Trip, P., de Man, F., Heymans, M. W., Marcus, J. T., Kawut, S. M., Bogaard, H.-J., Boonstra, A., & Vonk Noordegraaf, A. (2014) · Chest · doi:10.1378/chest.13-1291 · Cited by 231
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
McLaughlin, V., Channick, R. N., Ghofrani, H.-A., Lemarié, J.-C., Naeije, R., Packer, M., Souza, R., Tapson, V. F., Tolson, J., Al Hiti, H., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.02044-2014 · Cited by 228
Larkin, E. K., Newman, J. H., Austin, E. D., Hemnes, A. R., Wheeler, L., Robbins, I. M., West, J. D., Phillips, J. A., Hamid, R., & Loyd, J. E. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0886oc · Cited by 220
Pathogenesis of pulmonary arterial hypertension: lessons from cancer
Guignabert, C., Tu, L., Le Hiress, M., Ricard, N., Sattler, C., Seferian, A., Huertas, A., Humbert, M., & Montani, D. (2013) · European Respiratory Review · doi:10.1183/09059180.00007513 · Cited by 206
Self-citationMontani, D., Girerd, B., Jaïs, X., Levy, M., Amar, D., Savale, L., Dorfmüller, P., Seferian, A., Lau, E. M., Eyries, M., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30438-6 · Cited by 190
Self-citationGaliè, N., Müller, K., Scalise, A.-V., & Grünig, E. (2015) · European Respiratory Journal · doi:10.1183/09031936.00105914 · Cited by 188
The molecular targets of approved treatments for pulmonary arterial hypertension
Humbert, M. J. C., & Ghofrani, H. A. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207170 · Cited by 177
Self-citationTamby, M. C. (2005) · Thorax · doi:10.1136/thx.2004.029082 · Cited by 174
New Molecular Targets of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
Guignabert, C., Tu, L., Girerd, B., Ricard, N., Huertas, A., Montani, D., & Humbert, M. (2015) · Chest · doi:10.1378/chest.14-0862 · Cited by 173
Self-citationTu, L., Dewachter, L., Gore, B., Fadel, É., Dartevelle, P., Simonneau, G., Humbert, M. J. C., Eddahibi, S., & Guignabert, C. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0317oc · Cited by 173
Self-citationHassoun, P. M., Zamanian, R. T., Damico, R., Lechtzin, N., Khair, R., Kolb, T. M., Tedford, R. J., Hulme, O. L., Housten, T., Pisanello, C., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1398oc · Cited by 172
Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension
Poms, A. D., Turner, M., Farber, H. W., Meltzer, L. A., & McGoon, M. D. (2013) · Chest · doi:10.1378/chest.11-3241 · Cited by 163
The changing landscape of pulmonary arterial hypertension and implications for patient care
Hoeper, M. M., & Gibbs, J. S. R. (2014) · European Respiratory Review · doi:10.1183/09059180.00007814 · Cited by 158
Humbert, M. J. C., Coghlan, G., Ghofrani, H. A., Grimminger, F., He, J., Riemekasten, G., Vizza, C. D., Boeckenhoff, A., Meier, C., Pena, J. D. O., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209087 · Cited by 155
Self-citationInitial dual oral combination therapy in pulmonary arterial hypertension
Sitbon, O., Sattler, C., Bertoletti, L., Savale, L., Cottin, V., Jaïs, X., de Groote, P., Chaouat, A., Chabannes, C., Bergot, E., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.02043-2015 · Cited by 150
Self-citationZhao, L., Ashek, A., Wang, L., Fang, W., Dabral, S., Dubois, O., Cupitt, J., Pullamsetti, S. S., Cotroneo, E., Jones, H. A., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004136 · Cited by 142
Predicting survival in pulmonary arterial hypertension in the UK
Lee, W.-T. N., Ling, Y., Sheares, K. K. K., Pepke‐Żaba, J., Peacock, A. J., & Johnson, M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00196611 · Cited by 138
Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study
van Campen, J. S. J. A., de Boer, K., van de Veerdonk, M. C., van der Bruggen, C. E. E., Allaart, C. P., Raijmakers, P. G. H. M., Heymans, M. W., Marcus, J. T., Harms, H. J., Handoko, M. L., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00090-2016 · Cited by 110
Validation of two predictive models for survival in pulmonary arterial hypertension
Sitbon, O., Benza, R. L., Badesch, D. B., Barst, R. J., Elliott, C. G., Gressin, V., Lemarié, J.-C., Miller, D. P., Rouzic, E. M., Simonneau, G., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00004414 · Cited by 97
Self-citationLong-Term Data from the Swiss Pulmonary Hypertension Registry
Mueller‐Mottet, S., Stricker, H. J., Domeninghetti, G., Azzola, A., Geiser, T., Schwerzmann, M., Weilenmann, D., Schoch, O. D., Fellrath, J., Rochat, T., et al. (2015) · Respiration · doi:10.1159/000370125 · Cited by 87
Pulmonary Arterial Hypertension in the Southern Hemisphere
Alves, J. L., Gavilanes, F., Jardim, C., Fernandes, C. J. C. D. S., Morinaga, L. T. K., Dias, B., Hoette, S., Humbert, M. J. C., & Souza, R. (2014) · CHEST Journal · doi:10.1378/chest.14-1036 · Cited by 86
Self-citationJansa, P., Jarkovský, J., Al‐Hiti, H., Popelová, J., Ambrož, D., Zatočil, T., Votavová, R., Poláček, P., Marešová, J., Aschermann, M., et al. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-45 · Cited by 78
Sitbon, O., Delcroix, M., Bergot, E., Boonstra, A., Granton, J. T., Langleben, D., Subías, P. E., Galiè, N., Pfister, T., Lemarié, J., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.08.007 · Cited by 71
Cellular pathophysiology and therapy of pulmonary hypertension
Olschewski, H., Rose, F., Grünig, E., Ghofrani, H. A., WALMRATH, D., Schulz, R., SCHERMULY, R. T., Grimminger, F., & Seeger, W. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.119285 · Cited by 71
Survival of Japanese Patients With Idiopathic/Heritable Pulmonary Arterial Hypertension
Ogawa, A., Satoh, T., Tamura, Y., Fukuda, K., & Matsubara, H. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.01.015 · Cited by 69
Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension
Chung, W., Park, Y. B., Jeon, C. H., Jung, J. W., Ko, K. P., Choi, S. J., Seo, H., Lee, J. S., Jung, H. O., & KORPAH Investigators (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.10.1429 · Cited by 64
Treatment for Pulmonary Arterial Hypertension–Associated Right Ventricular Dysfunction
Gomez‐Arroyo, J. G., Sandoval, J., Simon, M. A. M., Dominguez-Cano, E., Voelkel, N. F., & Bogaard, H. J. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-425fr · Cited by 35
Charalampopoulos, A. F., Howard, L., Tzoulaki, I., Gin‐Sing, W., Grapsa, J., Wilkins, M. R., Davies, R. J., Nihoyannopoulos, P., Connolly, S. B., & Gibbs, J. S. R. (2014) · Pulmonary Circulation · doi:10.1086/678512 · Cited by 29
Jiang, X., Humbert, M. J. C., & Jing, Z. (2012) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000336068 · Cited by 18
Self-citation
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citationPredicting Survival in Patients With Pulmonary Arterial Hypertension
Benza, R. L., Gomberg-Maitland, M., Elliott, C. G., Farber, H. W., Foreman, A. J., Frost, A. E., McGoon, M. D., Pasta, D. J., Selej, M., Burger, C. D., et al. (2019) · Chest · doi:10.1016/j.chest.2019.02.004 · Cited by 643
Targeting SOCS proteins to control JAK-STAT signalling in disease
Durham, G. A., Williams, J. J. L., Nasim, M. T., & Palmer, T. M. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.03.001 · Cited by 183
Targeting the apelin system for the treatment of cardiovascular diseases
Chapman, F. A., Maguire, J. J., Newby, D. E., Davenport, A. P., & Dhaun, N. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad171 · Cited by 104
“122 Pulmonary arterial hypertension may be idiopathic, genetic, or secondary to a variety of causes including drugs (e.g. the appetite suppressant aminorex), infection (e.g. schistosomiasis), or multi-system disease (e.g. connective tissue diseases).”
Background
Metadata
- Authors
- Lau, E. M. T., Giannoulatou, E., Celermajer, D. S., & Humbert, M.
- Venue
- Nature Reviews Cardiology
- Published
- 2017-06-08
- Volume
- 14
- Issue
- 10
- Pages
- 603-614
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W2621496307
- Cited by
- 507
- References
- 107
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.